Crossmark

Efficacy of recombinant human GM-CSF compared to placebo for autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1186/s12890-026-04179-1

Published Online: 2026-02-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Naeem, Umaimah https://orcid.org/0009-0004-2317-6866
Zahid, Hafiza Fatima https://orcid.org/0009-0009-2250-0827
Imtiaz, Sarah https://orcid.org/0009-0003-0976-738X
Khan, Quratulain https://orcid.org/0009-0008-1856-7888
iftikhar, Ammara https://orcid.org/0009-0009-9976-9226
Azmat, Aliza https://orcid.org/0009-0002-3623-2252
Hafeez, Sadia https://orcid.org/0009-0007-1518-0824
parveen, Umaima https://orcid.org/0009-0008-1516-3757
Ali, Syed Hassan https://orcid.org/0009-0004-5360-6249
Paracha, Iqra https://orcid.org/0009-0006-7383-1755
Khan, Saweera https://orcid.org/0009-0007-2783-0097
Singh, Kalpana https://orcid.org/0000-0002-2273-5062
License Information

Text and Data Mining valid from 2026-02-25

Version of Record valid from 2026-03-31
More Information

Article History

Received: 17 November 2025

Accepted: 10 February 2026

First Online: 25 February 2026

Declarations

:

: Not Applicable.All authors agreed to participate.

: Not Applicable.

: The authors declare no competing interests.